0001493152-20-013071.txt : 20200710 0001493152-20-013071.hdr.sgml : 20200710 20200710125736 ACCESSION NUMBER: 0001493152-20-013071 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200709 FILED AS OF DATE: 20200710 DATE AS OF CHANGE: 20200710 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VAMVAKAS ELIAS CENTRAL INDEX KEY: 0001061865 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51030 FILM NUMBER: 201022635 MAIL ADDRESS: STREET 1: 5280 SOLAR DRIVE STREET 2: SUITE 100 CITY: MISSISSAUGA STATE: A6 ZIP: L4W 5M8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TearLab Corp CENTRAL INDEX KEY: 0001299139 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 593434771 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9980 HUENNEKENS ST. STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-794-1400 MAIL ADDRESS: STREET 1: 9980 HUENNEKENS ST. STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: OccuLogix, Inc. DATE OF NAME CHANGE: 20040730 4 1 ownership.xml X0306 4 2020-07-09 1 0001299139 TearLab Corp TEAR 0001061865 VAMVAKAS ELIAS 150 LA TERRAZA BLVD., STE 101 ESCONDIDO CA 92025 1 0 0 0 Common Stock 2020-07-09 4 U 0 20140 0.0586 D 0 D Common Stock 2020-07-09 4 U 0 130813 0.0586 D 0 I See footnote Common Stock 2020-07-09 4 U 0 32000 0.0586 D 0 I See footnote Pursuant to the terms of the Agreement and Plan of Merger, dated May 11, 2020 (the "Merger Agreement"), among Accelmed Partners II LP, a Cayman Islands exempted limited partnership ("Buyer"), the Issuer and Accelmed Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Buyer, each issued and outstanding share of Issuer common stock and preferred stock (other than Cancelled Shares (as defined in the Merger Agreement)) was cancelled and automatically converted into the right to receive an amount equal to $0.0586 per share in cash, without interest and less any required withholding taxes, effective at the time of the Merger (as defined in the Merger Agreement). Shares held by Greybrook Capital, Inc. The reporting person is an officer and a director of Greybrook Capital Inc. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Shares held by Greybrook Corporation. The reporting person is an officer and a director of Greybrook Corporation. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. /s/ Elias Vamvakas 2020-07-09